Horizon Discovery (LON:HZD) announced its chief business officer and executive director Dr David Smoller has left the company.
He joined in September 2014 as part of Horizon’s acquisition of Sage Labs and has stepped down by mutual agreement.
With Sage now successfully integrated into the company, Smoller will now leave to pursue other business interests, Horizon said.
Dr. Ian Gilham, chairman of Horizon, said Smoller has “assisted with the rapid integration of Sage Labs into the Horizon group and continued revenue growth of our services business.”
Horizon specialises in drug discovery and personalised medicine, supplying research tools to research organisations developing new medicines.